A Hybrid Effectiveness-implementation Evaluation on Programs Promoting Healthy Aging With Sport Exercise (PHASE Program)

Not Applicable

Recruiting

• Conditions: Ageing Well

• Registration Number: NCT06090253
• Lead Sponsor: The University of Hong Kong

Brief Summary

The goal of this clinical trial is to provide scientific evaluation on the effects of Promoting Healthy Aging with Sport Exercise (PHASE) Programs on the functional capacity of older. Based on the participants' mental well-being and physical health status, they will be provided with several tailored exercise intervention, including 1) football training; 2) gero-technology enhanced multi-component exercise; 3) slow sports and exercise; 4) walking exercise; 5) home-based exercise. A control group is also recruited and provided with no exercise intervention.

Detailed Description

This clinical trial is aimed to match a range of sport exercise to older adults who are in the different phase of transition along the continuum of intrinsic capacity, and to explore effective measures to promote healthy aging. The effectiveness of the tailored interventions will be tested among the six study arms of older adults with different intrinsic capacities, with five intervention arms and one control. Exercise intensity will be measured for each participant. The outcomes are overall health status, physical function, psychological function, and cognitive function. The outcomes are measured at baseline (pre-intervention), 3 months (post-intervention), and 6 months (post-intervention) to explore the program benefits.

Study Timeline

• Study Start: 2023-09-01
• Study First Submitted: 2023-10-13
• Study First Submitted QC: 2023-10-13
• Study First Posted: 2023-10-19
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-05
• Last Update Posted: 2024-12-06
• Primary Completion: 2026-08-31
• Study Completion: 2026-08-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1940

Inclusion Criteria

• Age above 60 years

Exclusion Criteria

• Any contraindication to exercise training

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mobility limitation score	Changes from baseline to 3 month and 6 month post-intervention.	Measured by Short Physical Performance Battery (range 0-12), higher score better physical performance
Sarcopenia risk score	Changes from baseline to 3 month and 6 month post-intervention	Measured by Sarcopenia(SARC) questionnaire and calf circumference in unit of cm (range0-20), higher score higher risk of sarcopenia
Functional mobility score	Changes from baseline to 3 month and 6 month post-intervention	Score measured by Life Space Assessment questionnaire (range: 0-120), higher score better performance
Hand grip strength	Changes from baseline to 3 month and 6 month post-intervention	Hand grip strength measured by hand-held dynamometer in unit of KG
Cognitive function score	Changes from baseline to 3 month and 6 month post-intervention	Measured by Montreal Cognitive Assessment (range 0-30), A score of 26 or over is considered to be normal.
Health status self-rated score	Changes from baseline to 3 month and 6 month post-intervention	Measure by EQ05D-5L (range -0.59-1.0), higher score better quality of life
Activity level	Changes from baseline to 3 month and 6 month post-intervention	Measured by International Physical Activity Questionnaire.
Loneliness score	Changes from baseline to 3 month and 6 month post-intervention	Measured by UCLA Loneliness Scale questionnaire (range20-80), higher score greater loneliness

Trial Locations

Locations (1)

The University of Hong Kong; 🇭🇰 Hong Kong, Hong Kong